KLK1 Protein (Kallikrein 1)
Introduction
flowchart TD
KLK1["KLK1"] -->|"therapeutic target"| Als["Als"]
KLK1["KLK1"] -->|"therapeutic target"| Neuroinflammation["Neuroinflammation"]
KLK1["KLK1"] -->|"therapeutic target"| Stroke["Stroke"]
KLK1["KLK1"] -->|"therapeutic target"| Atherosclerosis["Atherosclerosis"]
KLK1["KLK1"] -->|"therapeutic target"| Inflammation["Inflammation"]
KLK1["KLK1"] -->|"therapeutic target"| MET["MET"]
KLK1["KLK1"] -->|"interacts with"| PAH["PAH"]
KLK1["KLK1"] -->|"therapeutic target"| Oxidative_Stress["Oxidative Stress"]
KLK1["KLK1"] -->|"therapeutic target"| Stem_Cell["Stem Cell"]
MET["MET"] -->|"therapeutic target"| KLK1["KLK1"]
ABCC8["ABCC8"] -->|"interacts with"| KLK1["KLK1"]
OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"therapeutic target"| KLK1["KLK1"]
STROKE["STROKE"] -->|"therapeutic target"| KLK1["KLK1"]
AND["AND"] -->|"therapeutic target"| KLK1["KLK1"]
style KLK1 fill:#4fc3f7,stroke:#333,color:#000
KLK1 (Kallikrein 1) is a member of the kallikrein family of serine proteases, primarily known for its roles in the kinin system, blood pressure regulation, and inflammation. While predominantly studied in peripheral tissues, emerging evidence indicates KLK1 is expressed in the brain and may play complex roles in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD)[@kithcart2010][@scarisbrick2012].
...
KLK1 Protein (Kallikrein 1)
Introduction
Mermaid diagram (expand to render)
KLK1 (Kallikrein 1) is a member of the kallikrein family of serine proteases, primarily known for its roles in the kinin system, blood pressure regulation, and inflammation. While predominantly studied in peripheral tissues, emerging evidence indicates KLK1 is expressed in the brain and may play complex roles in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD)[@kithcart2010][@scarisbrick2012].
<div class="infobox infobox-protein">
Structure KLK1 is a secreted serine protease with classical protease architecture:
Signal peptide : N-terminal secretion signalPropeptide : Maintains latency until activation cleavageCatalytic domain : Serine protease fold with His-Asp-Ser catalytic triadKallikrein domain : Specific substrate binding regionThe active enzyme cleaves at specific arginine and lysine residues in target proteins[@borgono2003].
Normal Function
Kinin System
Bradykinin generation : Cleaves low and high molecular weight kininogens to release bradykininVasodilation : Bradykinin causes blood vessel relaxationBlood pressure : Contributes to blood pressure regulationPain and inflammation : Mediates inflammatory responsesAdditional Functions
Tissue remodeling : Proteolytic activity in extracellular matrixCoagulation : Interactions with clotting cascadeCell proliferation : Growth factor-like effectsRole in Neurodegeneration
Alzheimer's Disease
Brain expression : KLK1 is expressed in [neurons](/entities/neurons) and gliaAmyloid processing : May interact with [APP](/entities/app-protein) and [Aβ](/proteins/amyloid-beta) metabolismNeuroinflammation : Kinin system contributes to chronic inflammation[Blood-brain barrier](/entities/blood-brain-barrier) : May affect BBB integrityTherapeutic targeting : KLK1 inhibitors are being explored[@bitzer2019]Parkinson's Disease
Dopaminergic neurons : Expression in substantia nigraOxidative stress : Kinins may modulate oxidative responsesNeuroinflammation : Pro-inflammatory effects in PDMotor dysfunction : Kinin receptor involvement in motor controlStroke and Vascular Dementia
Blood-brain barrier : KLK1 contributes to BBB disruptionCerebral edema : Kinin-mediated vascular permeabilityHemorrhagic injury : Implications for stroke outcomesTherapeutic Implications
Kinin Receptor Antagonists
B1 receptor antagonists : Target inducible kinin receptorsB2 receptor antagonists : Block constitutive bradykinin effectsKLK1 Modulation
Inhibitors : Small molecule and peptide inhibitorsGene therapy : RNA-based approachesSee Also
[KLK1 Gene](/genes/klk1)
[Neuroinflammation in Parkinson's Disease](/mechanisms/neuroinflammation-parkinsons)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Blood-Brain Barrier Dysfunction](/mechanisms/blood-brain-barrier-dysfunction)
Kinin System in Neurodegeneration
Bradykinin Receptors The kinin system signals through two main receptors:
B1 receptor (BDKRB1) : Inducible, upregulated during inflammationB2 receptor (BDKRB2) : Constitutively expressed, mediates most bradykinin effectsNeuroinflammatory Effects Chronic neuroinflammation in AD and PD involves the kinin system:
Pro-inflammatory : Kinins potentiate cytokine releaseBlood-brain barrier : Increase BBB permeabilityEdema formation : Contribute to vasogenic edemaTherapeutic Targeting Kinin receptor antagonists represent potential therapeutics:
B1 antagonists : Icatibant, BI113823B2 antagonists : Lebrikizumab experimental compoundsKLK1 inhibitors : Reduce bradykinin generationReferences
[Kithcart A. et al., Kallikreins in inflammation (2010)](https://pubmed.ncbi.nlm.nih.gov/20184542/)
[Scarisbrick IA. et al., Kallikrein cascades in CNS injury (2012)](https://pubmed.ncbi.nlm.nih.gov/22160388/)
[Borgono CA. et al., Human kallikrein 14 (2003)](https://pubmed.ncbi.nlm.nih.gov/14534347/)
[Bitzer M. et al., Kallikrein in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/28943642/)
Pathway Diagram The following diagram shows the key molecular relationships involving KLK1 Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description